We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 27.50 | 1.59% | 1,761.00 | 1,757.50 | 1,758.00 | 1,767.00 | 1,736.00 | 1,736.00 | 14,302,622 | 16:35:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.69 | 72.38B |
TIDMGSK
RNS Number : 0730T
GlaxoSmithKline PLC
15 July 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
Hot Features
Premium
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Ms E Walmsley
==== ===================================== ====================================================
b) Position/status Chief Executive Officer
==== ===================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== =========================== =====================
GBP 15.9280 788
========================================== =========================== =====================
GBP 15.9280 784
=========================== =====================
GBP 15.9280 631
=========================== =====================
d) Aggregated information 2,203
====
Aggregated volume GBP15.9280
Price
========================================== ====================================================
e) Date of the transaction 2020-07-13
==== ===================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Dr H Barron
==== ======================================= ===================================================
b) Position/status Chief Scientific Officer and President,
R&D
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ===================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 9 July 2020 on ADSs held
in the Company's Deferred Annual Bonus
Plan.
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= ======================
$ 40.3700 455
============================================ ========================= ======================
$40.3700 357
========================= ======================
d) Aggregated information 812
====
Aggregated volume $40.3700
Price
============================================ ===================================================
e) Date of the transaction 2020-07-13
==== ======================================= ===================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Mr R Connor
==== ===================================== ====================================================
b) Position/status President, Global Vaccines
==== ===================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== =========================== =====================
GBP 15.9280 199
========================================== =========================== =====================
GBP 15.9280 205
=========================== =====================
GBP 15.9280 167
=========================== =====================
d) Aggregated information 571
====
Aggregated volume GBP15.9280
Price
========================================== ====================================================
e) Date of the transaction 2020-07-13
==== ===================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =============================================================================================
a) Name Ms D Conrad
==== ===================================== ======================================================
b) Position/status SVP Human Resources
==== ===================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =============================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ============================ =====================
GBP 15.9280 82
======================================================================= =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
==================================================================== ============================
e) Date of the transaction 2020-07-13
==== ===================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ==============================================================================================
a) Name Mr J Ford
==== ====================================== ======================================================
b) Position/status Senior Vice President and General Counsel
==== ====================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ==============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ==============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ====================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== =========================== ======================
GBP15.9280 117
======================================================================= ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
==================================================================== =============================
e) Date of the transaction 2020-07-13
==== ====================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =============================================================================================
a) Name Mr J Ford
==== ======================================= ====================================================
b) Position/status Senior Vice President and General Counsel
==== ======================================= ====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ====================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 9 July 2020 on ADSs held
in the Company's Deferred Annual Bonus
Plan.
==== ======================================= ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= ======================
$ 40.3700 39
========================= ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
======================================== ========================================================
e) Date of the transaction 2020-07-13
==== ======================================= ====================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Mr N Hirons
==== ===================================== ====================================================
b) Position/status SVP, Global Ethics & Compliance
==== ===================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== =========================== =====================
GBP 15.9280 87
========================================== =========================== =====================
GBP 15.9280 86
=========================== =====================
GBP 15.9280 61
=========================== =====================
d) Aggregated information 234
====
Aggregated volume GBP 15.9280
Price
========================================== ====================================================
e) Date of the transaction 2020-07-13
==== ===================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =============================================================================================
a) Name Ms S Jackson
==== ===================================== ======================================================
b) Position/status SVP, Global Communications & CEO Office
==== ===================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =============================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ============================ =====================
GBP 15.9280 49
======================================================================= =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume GBP 15.9280
Price
===================================== ===========================================================
e) Date of the transaction 2020-07-13
==== ===================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =============================================================================================
a) Name Mr I Mackay
==== ===================================== ======================================================
b) Position/status Chief Financial Officer
==== ===================================== ======================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ======================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =============================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ======================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ======================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ======================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ===================================== ======================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ============================ =====================
GBP 15.9280 426
======================================================================= =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume GBP 15.9280
Price
===================================== ===========================================================
e) Date of the transaction 2020-07-13
==== ===================================== ======================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== ======================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr B McNamara
==== ======================================= ===================================================
b) Position/status CEO, GSK Consumer Healthcare
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ===================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 9 July 2020 on ADSs held
in the Company's Deferred Annual Bonus
Plan.
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== --------------------------------------- ========================= ======================
$ 40.3700 76
-------------------------------------------- ========================= ======================
$ 40.3700 81
========================= ======================
$ 40.3700 65
------------------------- ----------------------
d) Aggregated information 222
====
Aggregated volume $ 40.3700
Price
============================================ ===================================================
e) Date of the transaction 2020-07-13
==== ======================================= ===================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr L Miels
==== ====================================== ====================================================
b) Position/status President, Global Pharmaceuticals
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP15.9280 158
=========================================== ========================== ======================
GBP15.9280 191
========================== ======================
GBP15.9280 219
========================== ======================
d) Aggregated information 568
====
Aggregated volume GBP15.9280
Price
=========================================== ====================================================
e) Date of the transaction 2020-07-13
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr D Redfern
==== ====================================== ====================================================
b) Position/status Chief Strategy Officer
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP15.9280 162
=========================================== ========================== ======================
GBP15.9280 194
========================== ======================
GBP15.9280 140
========================== ======================
d) Aggregated information 496
====
Aggregated volume GBP15.9280
Price
=========================================== ====================================================
e) Date of the transaction 2020-07-13
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr R Simard
==== ====================================== ====================================================
b) Position/status President, Pharmaceuticals Supply Chain
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP15.9280 99
=========================================== ========================== ======================
GBP15.9280 70
========================== ======================
d) Aggregated information 169
====
Aggregated volume GBP15.9280
Price
=========================================== ====================================================
e) Date of the transaction 2020-07-13
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Ms K Terrell
==== ======================================= ===================================================
b) Position/status Chief Digital & Technology Officer
==== ======================================= ===================================================
c) Initial notification/ Initial notification
amendment
==== ======================================= ===================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================= ===================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================= ===================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================= ===================================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 9 July 2020 on ADSs held
in the Company's Deferred Annual Bonus
Plan.
==== ======================================= ===================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================= ========================= ======================
$ 40.3700 27
============================================ ========================= ======================
$ 40.3700 97
========================= ======================
$40.3700 66
========================= ======================
d) Aggregated information 190
====
Aggregated volume $ 40.3700
Price
============================================ ===================================================
e) Date of the transaction 2020-07-13
==== ======================================= ===================================================
f) Place of the New York Stock Exchange (XNYS)
transaction
==== ======================================= ===================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr P Thomson
==== ====================================== ====================================================
b) Position/status President, Global Affairs
==== ====================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ====================================== ====================================================
b) Nature of the Increase in notional interest in Ordinary
transaction Shares following the re-investment of dividends
paid to shareholders on 9 July 2020 on
Ordinary Shares held in the Company's Deferred
Annual Bonus Plan.
==== ====================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================== ======================
GBP15.9280 109
=========================================== ========================== ======================
GBP15.9280 113
========================== ======================
GBP15.9280 80
========================== ======================
d) Aggregated information 302
====
Aggregated volume GBP15.9280
Price
=========================================== ====================================================
e) Date of the transaction 2020-07-13
==== ====================================== ====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== ====================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHVELBFBDLLBBK
(END) Dow Jones Newswires
July 15, 2020 04:31 ET (08:31 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
